Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) Net Margin (2022 - 2025)

Medinotec filings provide 4 years of Net Margin readings, the most recent being 15.9% for Q4 2025.

  • On a quarterly basis, Net Margin rose 380.0% to 15.9% in Q4 2025 year-over-year; TTM through Nov 2025 was 38.06%, a 2507.0% increase, with the full-year FY2025 number at 41.27%, up 4471.0% from a year prior.
  • Net Margin hit 15.9% in Q4 2025 for Medinotec, up from 10.59% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 87.35% in Q1 2025 to a low of 161.39% in Q3 2022.
  • Median Net Margin over the past 4 years was 6.31% (2022), compared with a mean of 5.58%.
  • The widest YoY moves for Net Margin: up 14884bps in 2023, down -3025bps in 2023.
  • Medinotec's Net Margin stood at 5.66% in 2022, then tumbled by -534bps to 24.59% in 2023, then surged by 149bps to 12.1% in 2024, then soared by 31bps to 15.9% in 2025.
  • The last three reported values for Net Margin were 15.9% (Q4 2025), 10.59% (Q3 2025), and 24.63% (Q2 2025) per Business Quant data.